Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Dutasteride and Tamoxifen Interaction: Avoid | Peptide Database

Compound Profiles Dutasteride Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, whi

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Dutasteride

Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH

Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, while Type I is found primarily in the skin, sebaceous glands, and liver.

Tamoxifen

Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment

Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Dutasteride with Tamoxifen?

Combining Dutasteride with Tamoxifen is not recommended. Both Dutasteride and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Dutasteride and Tamoxifen safe together?

This combination carries significant risk. Both Dutasteride and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Dutasteride and Tamoxifen?

Both Dutasteride and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.

How should I time Dutasteride and Tamoxifen?

Dutasteride has a half-life of ~5 weeks (extremely long; active metabolite accumulation over months) and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Research explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation. May support overall urinary tract function and tissue health. Potential benefits for pelvic tissue health and function. Research indicates potential to enhance blood flow and reduce dysfunction in prostate tissue. May help alleviate symptoms associated with benign prostatic hyperplasia. Part of comprehensive bioregulator protocols addressing age-related urogenital changes. Supports cellular regeneration in urinary and reproductive tissues.

Source: peptide-db.com ↗

Research Indications

MENT is being investigated as an alternative to testosterone for androgen replacement. Its high potency allows for low-volume injections, and unlike nandrolone it maintains sexual function without requiring a concurrent testosterone base. Subdermal implant formulations have been studied to provide sustained release over months, potentially offering a more convenient delivery method than testosterone injections. MENT's primary clinical research focus. Phase 2 trials have demonstrated that MENT, alone or in combination with a progestin, can suppress spermatogenesis to azoospermia or severe oligospermia in the majority of men. The contraceptive effect is reversible upon discontinuation. MENT's advantage over testosterone-based contraceptive approaches is its greater potency and the fact that it does not require 5-alpha reduction for full androgenic activity. MENT produces significant dose-dependent increases in lean body mass. Due to its potency being roughly 10 times that of testosterone, even low doses (5-10 mg/day) can produce anabolic effects comparable to moderate doses of testosterone. Higher doses (15-25 mg/day) produce substantial muscle growth but with increased side effect burden, particularly estrogenic effects. Users consistently report rapid and significant strength increases on MENT, often noticeable within the first 1-2 weeks due to the fast-acting acetate ester. Strength gains appear to scale with dose and are accompanied by notable improvements in training recovery. Unlike nandrolone and trenbolone (other 19-nor compounds), MENT maintains libido and erectile function because it acts directly on androgen receptors in the brain and sexual tissues without being reduced to a weaker metabolite. Many users report enhanced libido on MENT, particularly at lower doses before estrogenic side effects become prominent.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Winstrol is available as an oral tablet, typically in 10 mg and 50 mg dosages. As a 17-alpha-alkylated steroid, it survives first-pass hepatic metabolism but carries significant hepatotoxic potential. Oral winstrol has a half-life of approximately 9 hours, necessitating split dosing for stable blood levels. The oral form is the most commonly used and is known for being particularly harsh on lipid profiles and liver values compared to most other oral steroids. Medical - Hereditary Angioedema 2 mg three times daily Three times daily Oral Performance - Conservative 25 mg/day Split into 2-3 doses daily Performance - Standard 50 mg/day Split into 2 doses (morning and evening)

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →